Dexela

Fast, Low Dose X-Ray Imaging

Dexela is a market leading innovator of technologies for fast, low-dose 3D X-ray imaging applications.

Dexela is active in several market segments and is developing a range of technologies including 3D breast imaging technology for the early detection of breast cancer, known as Tomosynthesis.

Dexela London Headquarters


Dexela News 
Dexela to exhibit at RSNA 200805 November 2008
Dexela fund raising of £2.6 Million 17 July 2008
Dexela appoints Peter Denyer as Director and Non-Executive Chairman01 July 2008
Dexela wins International Trade Award30 June 2008
Dexela exhibits DexTop, its state of the art 3D mammography workstation, at the DRK conference in Berlin, 30 April – 3 May 200802 May 2008

Breast Cancer News
The Medscape Radiology RSS Feed Has Moved22 November 2008



Dexela at RSNA 2008
Dexela will be exhibiting on the NDS Surgical Imaging booth 4029 in the south building at this years RSNA in Chicago.


Dexela fund raising of £2.6 Million
Dexela Limited is pleased to announce that it has raised more than £2.6 million through the issue of shares. The main investors in this funding round included Close Ventures and London Technology Fund.


Dexela gains ISO certification
Dexela has achieved ISO 13485 and ISO 9001 certification for its quality management system. The quality management system has been certified by Lloyd’s Register Quality Assurance Limited. The accredited certification body has verified that the organization and all the functions of Dexela fulfil the requirements stated in the standards ISO 9001 and ISO 13485.


Dexela extends strategic partnership with XCounter
Dexela has deepened its strategic relationship with XCounter AB, the developer of the innovative XC Mammo -3T scanner and other 3D X-ray technologies.


   © Dexela Limited 2008 Registered Company 04797594